Moderna Inc (MRNA)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$145.03

Buy

$145.39

arrow-up$7.35 (+5.38%)

Prices updated at 11 Sep 2026, 11:59 EDT

Prices minimum 15 mins delay

Prices in USD

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna ha ...

NASDAQ

0.96%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$149.73 - $135.01
	$176.66 - $22.28
	-
	57,477.99m
	-
	-
	84,700
	8.50
	11,580,927.53
	0.74
	394.00m
	US60770K1079
	-7.26
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.